B-type natriuretic peptide for risk stratification in community-acquired pneumonia

J Intern Med. 2005 Oct;258(4):391-3. doi: 10.1111/j.1365-2796.2005.01540.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Area Under Curve
  • Biomarkers / blood
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / mortality
  • Community-Acquired Infections / blood
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / mortality
  • Female
  • Humans
  • Lung Diseases / blood
  • Lung Diseases / complications
  • Lung Diseases / mortality
  • Male
  • Natriuretic Peptide, Brain / blood*
  • Pneumonia / blood*
  • Pneumonia / complications
  • Pneumonia / mortality
  • Risk Assessment

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain